and there were negative side effects that caused many to drop out.
Vertex charges $259,000, every year, for a 2% improvement with the side effects that caused half to drop out thrown in for free.
The placebo is equally effective and has no side effects.
Would you pay $300,000 for a 1.7% questionable improvement in breathing, multiple side effects that half the patients dropped out, and the possible efficacy quickly wore off.
Only 15 found a 1.7% improvment on Orkambi and the FDA hasn't got a clue which of the two drugs had any effects.
and certainly not fundable at $300.000.00 a year with declining and questionable results on only 15 patients.
It is far cheaper to do a lung transplant.
for a few bucks instead of spending $300,000 for the side effects. Nobody is going to buy or fund this #$%$ no matter who approves Orscambi.
Let's see, TSLA is a leader in electric cars, spaceships, and energy power packs. VRTX has 1 drug approved for 2000 patients if they could afford it.
They have sold out knowing this new application is USELESS.